BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3:18. [PMID: 28930128 DOI: 10.3390/medicines3030018] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 9.6] [Reference Citation Analysis]
Number Citing Articles
1 Omagari K, Suruga K, Kyogoku A, Nakamura S, Sakamoto A, Nishioka S, Ichimura M, Miyata Y, Tajima K, Tsuneyama K, Tanaka K. A fermented mixed tea made with camellia (Camellia japonica) and third-crop green tea leaves prevents nonalcoholic steatohepatitis in Sprague-Dawley rats fed a high-fat and high-cholesterol diet. Hepatobiliary Surg Nutr 2018;7:175-84. [PMID: 30046568 DOI: 10.21037/hbsn.2017.08.03] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Wang T, Zhao X, Shao C, Ye L, Guo J, Peng N, Zhang H, Li J, Kong Y, You H, Jia J. A proposed pathologic sub-classification of drug-induced liver injury. Hepatol Int 2019;13:339-51. [PMID: 30977034 DOI: 10.1007/s12072-019-09940-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Teschke R. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Front Pharmacol 2019;10:730. [PMID: 31396080 DOI: 10.3389/fphar.2019.00730] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
4 Lin H, Ewing LE, Koturbash I, Gurley BJ, Miousse IR. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects. Food Chem Toxicol 2017;110:229-39. [PMID: 29042291 DOI: 10.1016/j.fct.2017.10.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
5 Zhang F, Zhou Y, Yang X, Xiong AZ, Wang ZT, Yang L. Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors. Acta Pharmacol Sin 2019;40:781-9. [PMID: 30367152 DOI: 10.1038/s41401-018-0155-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
6 Teschke R, Eickhoff A, Wolff A, Xuan TD. Liver Injury from Herbs and “Dietary Supplements”: Highlights of a Literature Review from 2015 to 2017. Curr Pharmacol Rep 2018;4:120-31. [DOI: 10.1007/s40495-018-0124-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Xiong A, Shao Y, Fang L, Yang X, Zhang S, Zheng J, Ding W, Yang L, Wang Z. Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice. Phytomedicine 2019;54:77-88. [PMID: 30668385 DOI: 10.1016/j.phymed.2018.06.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
8 Teschke R. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin Drug Metab Toxicol. 2018;14:1169-1187. [PMID: 30354694 DOI: 10.1080/17425255.2018.1539077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
9 Liu Y, Wang Q, Yang J, Guo X, Liu W, Ma S, Li S. Polygonum multiflorum Thunb.: A Review on Chemical Analysis, Processing Mechanism, Quality Evaluation, and Hepatotoxicity. Front Pharmacol 2018;9:364. [PMID: 29713283 DOI: 10.3389/fphar.2018.00364] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
10 Zhu Y, Niu M, Wang JB, Wang RL, Li JY, Ma YQ, Zhao YL, Zhang YF, He TT, Yu SM, Guo YM, Zhang F, Xiao XH, Schulze J. Predictors of poor outcomes in 488 patients with herb-induced liver injury. Turk J Gastroenterol. 2019;30:47-58. [PMID: 30289391 DOI: 10.5152/tjg.2018.17847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sun W, Gao Y, Yu X, Yuan Y, Yi J, Zhang Z, Cheng Y, Li Y, Peng X, Cha X. 'Psoriasis 1' reduces psoriasis‑like skin inflammation by inhibiting the VDR‑mediated nuclear NF‑κB and STAT signaling pathways. Mol Med Rep 2018;18:2733-43. [PMID: 30015892 DOI: 10.3892/mmr.2018.9262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
12 Gao Y, Wang Z, Tang J, Liu X, Shi W, Qin N, Wang X, Pang Y, Li R, Zhang Y, Wang J, Niu M, Bai Z, Xiao X. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions. Front Med 2020;14:68-80. [PMID: 30924023 DOI: 10.1007/s11684-019-0690-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Tu C, He Q, Li CY, Niu M, Han ZX, Ge FL, Zhou YY, Zhang L, Wang XH, Zhu JX, Li RS, Song HB, Xiao XH, Wang JB. Susceptibility-Related Factor and Biomarkers of Dietary Supplement Polygonum multiflorum-Induced Liver Injury in Rats. Front Pharmacol 2019;10:335. [PMID: 31024306 DOI: 10.3389/fphar.2019.00335] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
14 Wei Y, Liu M, Liu J, Li H. Influence Factors on the Hepatotoxicity of Polygoni Multiflori Radix. Evid Based Complement Alternat Med 2019;2019:5482896. [PMID: 31662776 DOI: 10.1155/2019/5482896] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Teschke R. Alcoholic Liver Disease: Alcohol Metabolism, Cascade of Molecular Mechanisms, Cellular Targets, and Clinical Aspects. Biomedicines 2018;6:E106. [PMID: 30424581 DOI: 10.3390/biomedicines6040106] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 15.3] [Reference Citation Analysis]
16 Schueller F, Roy S, Vucur M, Trautwein C, Luedde T, Roderburg C. The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int J Mol Sci. 2018;19:pii: E261. [PMID: 29337905 DOI: 10.3390/ijms19010261] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 17.3] [Reference Citation Analysis]
17 Liang J, Chen Y, Ren G, Dong W, Shi M, Xiong L, Li J, Dong J, Li F, Yuan J. Screening Hepatotoxic Components in Euodia rutaecarpa by UHPLC-QTOF/MS Based on the Spectrum-Toxicity Relationship. Molecules 2017;22:E1264. [PMID: 28749432 DOI: 10.3390/molecules22081264] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
18 Wang X, Zhang W, Yang Y, Chen Y, Zhuge Y, Xiong A, Yang L, Wang Z. Blood microRNA Signatures Serve as Potential Diagnostic Biomarkers for Hepatic Sinusoidal Obstruction Syndrome Caused by Gynura japonica Containing Pyrrolizidine Alkaloids. Front Pharmacol 2021;12:627126. [PMID: 33679405 DOI: 10.3389/fphar.2021.627126] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B 2017;18:194-214. [PMID: 28271656 DOI: 10.1631/jzus.B1600299] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
20 Guo G, Zhou J, Yang X, Feng J, Shao Y, Jia T, Huang Q, Li Y, Zhong Y, Nagarkatti PS, Nagarkatti M. Role of MicroRNAs Induced by Chinese Herbal Medicines Against Hepatocellular Carcinoma: A Brief Review. Integr Cancer Ther 2018;17:1059-67. [PMID: 30343602 DOI: 10.1177/1534735418805564] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Teschke R, Xuan TD. Suspected herb induced liver injury by green tea extracts: Critical review and case analysis applying RUCAM for causality assessment.Japanese J Gastroenterol Hepatol. 2019;6:1-16. [DOI: 10.21037/tgh-20-149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Xia C, Liu Y, Yao H, Zhu W, Ding J, Jin J. Causality assessment of skyfruit-induced liver injury using the updated RUCAM: a case report and review of the literature. J Int Med Res 2020;48:300060520917569. [PMID: 32293220 DOI: 10.1177/0300060520917569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Anh H, Quan NV, Lam VQ, Iuchi Y, Takami A, Teschke R, Xuan TD. Antioxidant, Anti-tyrosinase, Anti-α-amylase, and Cytotoxic Potentials of the Invasive Weed Andropogon virginicus. Plants (Basel) 2020;10:E69. [PMID: 33396235 DOI: 10.3390/plants10010069] [Reference Citation Analysis]
24 Zhang L, Wang T, Zhao BS, Zhang JX, Yang S, Fan CL, Li P. Effect of 2″-O-Rhamnosyl Icariside II, Baohuoside I and Baohuoside II in Herba Epimedii on Cytotoxicity Indices in HL-7702 and HepG2 Cells. Molecules 2019;24:E1263. [PMID: 30939785 DOI: 10.3390/molecules24071263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
25 Wu ZT, Li ZQ, Shi W, Wang LL, Jiang Y, Li P, Li HJ. The crucial role of metabolic regulation in differential hepatotoxicity induced by furanoids in Dioscorea bulbifera. Chin J Nat Med 2020;18:57-69. [PMID: 31955824 DOI: 10.1016/S1875-5364(20)30005-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Uetrecht J. Mechanistic Studies of Idiosyncratic DILI: Clinical Implications. Front Pharmacol 2019;10:837. [PMID: 31402866 DOI: 10.3389/fphar.2019.00837] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
27 Danan G, Teschke R. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? Drug Saf. 2018;41:735-743. [PMID: 29502198 DOI: 10.1007/s40264-018-0654-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 14.7] [Reference Citation Analysis]
28 Yang H, Guo D, Xu Y, Zhu M, Yao C, Chen C, Jia W. Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods. Front Pharmacol 2019;10:816. [PMID: 31379581 DOI: 10.3389/fphar.2019.00816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Teschke R. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opin Pharmacother 2018;19:779-93. [PMID: 29708448 DOI: 10.1080/14656566.2018.1465929] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
30 Danan G, Teschke R. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future. Front Pharmacol. 2019;10:853. [PMID: 31417407 DOI: 10.3389/fphar.2019.00853] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
31 He S, Zhang X, Lu S, Zhu T, Sun G, Sun X. A Computational Toxicology Approach to Screen the Hepatotoxic Ingredients in Traditional Chinese Medicines: Polygonum multiflorum Thunb as a Case Study. Biomolecules 2019;9:E577. [PMID: 31591318 DOI: 10.3390/biom9100577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
32 Kim TW. Ginseng for Liver Injury: Friend or Foe? Medicines (Basel) 2016;3:E33. [PMID: 28930143 DOI: 10.3390/medicines3040033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
33 Brown AC. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food and Chemical Toxicology 2017;107:449-71. [DOI: 10.1016/j.fct.2016.11.001] [Cited by in Crossref: 81] [Cited by in F6Publishing: 54] [Article Influence: 20.3] [Reference Citation Analysis]
34 Uhl M, Schwab S, Efferth T. Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature. Front Oncol 2016;6:204. [PMID: 27774434 DOI: 10.3389/fonc.2016.00204] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
35 Teschke R, Danan G. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol. 2017;13:425-438. [PMID: 27822971 DOI: 10.1080/17425255.2017.1252749] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
36 Lin L, Li H, Lin H, Zhang M, Qu C, Yan L, Yin X, Ni J. A New Perspective on Liver Injury by Traditional Chinese Herbs Such As Polygonum multiflorum: The Geographical Area of Harvest As an Important Contributory Factor. Front Pharmacol 2017;8:349. [PMID: 28676759 DOI: 10.3389/fphar.2017.00349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
37 Meunier L, Larrey D. Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation. Front Pharmacol 2019;10:1482. [PMID: 31920666 DOI: 10.3389/fphar.2019.01482] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
38 Cope RB. Toxicology and Drug Interactions of Nutraceuticals. In: Gupta RC, Srivastava A, Lall R, editors. Nutraceuticals in Veterinary Medicine. Cham: Springer International Publishing; 2019. pp. 711-27. [DOI: 10.1007/978-3-030-04624-8_51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Teschke R, Vongdala N, Quan NV, Quy TN, Xuan TD. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update. Int J Mol Sci 2021;22:10419. [PMID: 34638760 DOI: 10.3390/ijms221910419] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Teschke R, Danan G. Drug induced liver injury with analysis of alternative causes as confounding variables. Br J Clin Pharmacol 2018;84:1467-77. [PMID: 29607530 DOI: 10.1111/bcp.13593] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
41 Li Q, Zhang X, Wang X, Zhao T, Qiu C, Zhou B. Detection Method and System of the Human Body Characteristic Index Based on TCM. J Healthc Eng 2021;2021:5549842. [PMID: 33986941 DOI: 10.1155/2021/5549842] [Reference Citation Analysis]
42 Tan Y, Chen H, Zhou X, Sun L. RUCAM-based assessment of liver injury by xiang-tian-guo (Swietenia macrophylla) seeds, a plant used for treatment of hypertension and diabetes. Ann Hepatol 2019;18:406-7. [PMID: 31056362 DOI: 10.1016/j.aohep.2019.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
43 Liu B, Fan D, Sun W, Zheng K, Pang G, He X, Xiao C, Lu C. Zhuang Gu Guan Jie Wan: Reasonable Application Can Alleviate the Liver Injury for Osteoarthritis Treatment. Evid Based Complement Alternat Med 2018;2018:6716529. [PMID: 30538762 DOI: 10.1155/2018/6716529] [Reference Citation Analysis]
44 Jing J, Teschke R. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury. J Clin Transl Hepatol 2018;6:57-68. [PMID: 29577033 DOI: 10.14218/JCTH.2017.00033] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
45 Teschke R, Schulze J, Eickhoff A, Danan G. Drug Induced Liver Injury: Can Biomarkers Assist RUCAM in Causality Assessment? Int J Mol Sci. 2017;18:E803. [PMID: 28398242 DOI: 10.3390/ijms18040803] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
46 Brewer CT, Chen T. Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450. Int J Mol Sci 2017;18:E2353. [PMID: 29117101 DOI: 10.3390/ijms18112353] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
47 Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J Hepatol 2017; 9(29): 1141-1157 [PMID: 29085558 DOI: 10.4254/wjh.v9.i29.1141] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
48 Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
49 Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
50 Thomford NE, Dzobo K, Chimusa E, Andrae-marobela K, Chirikure S, Wonkam A, Dandara C. Personalized Herbal Medicine? A Roadmap for Convergence of Herbal and Precision Medicine Biomarker Innovations. OMICS: A Journal of Integrative Biology 2018;22:375-91. [DOI: 10.1089/omi.2018.0074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
51 Teschke R, Schulze J. Green tea and the question of reduced liver cancer risk: the dawn of potential clinical relevance? Hepatobiliary Surg Nutr 2017;6:122-6. [PMID: 28503560 DOI: 10.21037/hbsn.2017.03.03] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]